Metropolitan Life Insurance Company (MetLife)’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-69
| Closed | -$7.05K | – | 2457 |
|
|
2023
Q2 | $7.05K | Buy |
69
+34
| +97% | +$3.47K | ﹤0.01% | 2427 |
|
|
2023
Q1 | $6.24K | Sell |
35
-48
| -58% | -$8.56K | ﹤0.01% | 2261 |
|
|
2022
Q4 | $32.1K | Hold |
83
| – | – | ﹤0.01% | 1753 |
|
|
2022
Q3 | $28K | Hold |
83
| – | – | ﹤0.01% | 1833 |
|
|
2022
Q2 | $27.3K | Hold |
83
| – | – | ﹤0.01% | 1884 |
|
|
2022
Q1 | $36.3K | Sell |
83
-254
| -75% | -$111K | ﹤0.01% | 1770 |
|
|
2021
Q4 | $148K | Sell |
337
-33
| -9% | -$14.5K | ﹤0.01% | 2230 |
|
|
2021
Q3 | $206K | Hold |
370
| – | – | ﹤0.01% | 2049 |
|
|
2021
Q2 | $190K | Buy |
370
+13
| +4% | +$6.68K | ﹤0.01% | 2180 |
|
|
2021
Q1 | $279K | Hold |
357
| – | – | ﹤0.01% | 1791 |
|
|
2020
Q4 | $194K | Hold |
357
| – | – | ﹤0.01% | 1958 |
|
|
2020
Q3 | $163K | Hold |
357
| – | – | ﹤0.01% | 1910 |
|
|
2020
Q2 | $220K | Hold |
357
| – | – | ﹤0.01% | 1734 |
|
|
2020
Q1 | $170K | Buy |
357
+14
| +4% | +$6.66K | ﹤0.01% | 1684 |
|
|
2019
Q4 | $199K | Sell |
343
-24
| -7% | -$13.9K | ﹤0.01% | 1935 |
|
|
2019
Q3 | $242K | Buy |
367
+51
| +16% | +$33.6K | ﹤0.01% | 1746 |
|
|
2019
Q2 | $245K | Hold |
316
| – | – | ﹤0.01% | 1762 |
|
|
2019
Q1 | $223K | Hold |
316
| – | – | ﹤0.01% | 1832 |
|
|
2018
Q4 | $148K | Buy |
+316
| New | +$148K | ﹤0.01% | 2016 |
|
|
2018
Q3 | – | Sell |
-241
| Closed | -$166K | – | 2629 |
|
|
2018
Q2 | $166K | Hold |
241
| – | – | ﹤0.01% | 2055 |
|
|
2018
Q1 | $108K | Hold |
241
| – | – | ﹤0.01% | 2254 |
|
|
2017
Q4 | $106K | Sell |
241
-219
| -48% | -$96.3K | ﹤0.01% | 2280 |
|
|
2017
Q3 | $227K | Hold |
460
| – | – | ﹤0.01% | 2208 |
|
|
2017
Q2 | $255K | Hold |
460
| – | – | ﹤0.01% | 2183 |
|
|
2017
Q1 | $305K | Buy |
+460
| New | +$305K | ﹤0.01% | 1989 |
|
|
2016
Q1 | – | Sell |
-371
| Closed | -$225K | – | 2527 |
|
|
2015
Q4 | $225K | Buy |
371
+25
| +7% | +$15.2K | ﹤0.01% | 2175 |
|
|
2015
Q3 | $178K | Buy |
+346
| New | +$178K | ﹤0.01% | 2363 |
|